Skip to main content
. 2024 Mar 28;15:1352744. doi: 10.3389/fimmu.2024.1352744

Table 1.

Overview of microbial changes in patients with ME/CFS cases compared to healthy controls (HC) [modified after (33, 35)].

Study Subjects Year Country Intestinal dysbiosis Reduced microbiota Enhanced microbiota Reference
1 2076 cases, 460,857 HC 2023 11 countries Yes None Anaerobic bacteria (e.g. Paraprevotella, Ruminococcaceae UCG_014) He et al., 2023 (36),
2 35 cases, 70 HC (Fukuda Criteria) 2021 Italy Yes Firmicutes Bacteroidetes Lupo et al., 2021 (13),
3 48 cases, 52 HC (Fukuda und International Consensus Criteria) 2020 Japan Yes None Blautia, Coprobacillus, Eggerthella Kitami et al., 2020 (37),
4 17 cases und 17 HC (Fukuda Criteria) 2018 USA No None None Mandarano et al., 2018 (38),
5 50 cases, 50 HC (Fukuda, Canadian Criteria) 2017 USA Yes Faecalibacterium (with IBS), Bacteroides vulgatus (without IBS) Alistipes (with IBS), Bacteroides (without IBS) Nagy-Szakal et al.2017 (34),
6 48 cases, 39 HC (Fukuda Criteria) 2016 USA Yes Firmicutes (n.s.), anti-inflammatory species (n.s.) Pro-inflammatory species, Proteaobacteria (e.g. Enterobacteriaceae) Giloteaux et al., 2016 (39),
7 1 case, 1 HC (34-year-old monozytogenic male twins) (Fukuda Criteria) 2016 USA Yes Faecalibacterium, Bifidobacterium None Giloteaux et al., 2016 (40),
8 34 cases and 25 HC (Canadian Criteria) 2016 Australia Yes Anaerobic bacteria, Bacteroides spp. Aerobic bacteria (n.s.), Clostridium spp. Armstrong et al., 2016 (41),
9 10 cases, 10 HC (Fukuda criteria) 2015 Italy Yes Actinobacteria; Firmicutes (n.s.) Bacteroidetes (n.s.) Shukla et al., 2015 (42),
10 35 cases, 36 HC (Fukuda criteria) 2013 Belgium Yes Firmicutes Bacteroidetes (e.g. Alistipes) Frémont et al., 2013 (43),
11 108 cases and 177 HC (Holmes, Fukuda and Canadian criteria) 2009 Australia Yes E. coli, Gram-positive/Gram-negative bacteria ratio Aerobic bacteria, D-lactic acid producing: E. faecalis, S. sanguinis Sheddy et al., 2009 (44),

IBS, irritable bowel syndrome, n.s., non significant.